TECHNOLOGY AT THE SERVICE OF BIOLOGY
The health crisis has given the biotech sector an unprecedented boost. At a time when vaccination campaigns are in full swing in Europe, biotech companies have demonstrated their central role in the race for a vaccine. The public’s focus on efficacy and safety is driving these companies to make greater use of artificial intelligence and data analysis. As a result, the health sector is moving towards increasingly personalized medicine.
This month, we take a look at the world of biotech through two dedicated articles and the interview of an expert in this forward-looking sector.